Literature DB >> 17823313

A novel phosphodiesterase type 4 inhibitor, HT-0712, enhances rehabilitation-dependent motor recovery and cortical reorganization after focal cortical ischemia.

Erin MacDonald1, Heidi Van der Lee, David Pocock, Christy Cole, Nagheme Thomas, Penny M VandenBerg, Rusiko Bourtchouladze, Jeffrey A Kleim.   

Abstract

Rehabilitation-dependent motor recovery after cerebral ischemia is associated with functional reorganization of residual cortical tissue. Recovery is thought to occur when remaining circuitry surrounding the lesion is "retrained" to assume some of the lost function. This reorganization is in turn supported by synaptic plasticity within cortical circuitry and manipulations that promote plasticity may enhance recovery. Activation of the cAMP/CREB pathway is a key step for experience-dependent neural plasticity. Here we examined the effects of the prototypical phosphodiesterase inhibitor 4 (PDE4) rolipram and a novel PDE inhibitor (HT-0712), known to enhance cAMP/CREB signaling and cognitive function, on restoration of motor skill and cortical function after focal cerebral ischemia. Adult male rats were trained on a skilled reaching task to establish a baseline level of motor performance. Intracortical microstimulation was then used to derive high-resolution maps of forelimb movement representations within the caudal forelimb area of motor cortex contralateral to the trained paw. A focal ischemic infarct was created within approximately 30% of the caudal forelimb area. The effects of administering either rolipram or the novel PDE4 inhibitor HT-0712 during rehabilitation on motor recovery and restoration of movement representations within residual motor cortex were examined. Both compounds significantly enhanced motor recovery and induced an expansion of distal movement representations that extended beyond residual motor cortex. The expansion beyond the initial residual cortex was not observed in vehicle injected controls. Furthermore, the motor recovery seen in the HT-0712 animals was dose dependent. Our results suggest that PDE4 inhibitors during motor rehabilitation facilitate behavioral recovery and cortical reorganization after ischemic insult to levels significantly greater than that observed with rehabilitation alone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823313     DOI: 10.1177/1545968307305521

Source DB:  PubMed          Journal:  Neurorehabil Neural Repair        ISSN: 1545-9683            Impact factor:   3.919


  21 in total

1.  Translating concepts of neural repair after stroke: Structural and functional targets for recovery.

Authors:  Robert W Regenhardt; Hajime Takase; Eng H Lo; David J Lin
Journal:  Restor Neurol Neurosci       Date:  2020       Impact factor: 2.406

2.  Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons.

Authors:  Brian P Head; Yue Hu; J Cameron Finley; Michelle D Saldana; Jacqueline A Bonds; Atsushi Miyanohara; Ingrid R Niesman; Sameh S Ali; Fiona Murray; Paul A Insel; David M Roth; Hemal H Patel; Piyush M Patel
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

Review 3.  Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments.

Authors:  Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2008 Mar-Apr       Impact factor: 3.919

Review 4.  Promoting axonal rewiring to improve outcome after stroke.

Authors:  Larry I Benowitz; S Thomas Carmichael
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

5.  The PDE4 inhibitor HT-0712 improves hippocampus-dependent memory in aged mice.

Authors:  Marco Peters; Matthew Bletsch; Jennifer Stanley; Damian Wheeler; Roderick Scott; Tim Tully
Journal:  Neuropsychopharmacology       Date:  2014-06-26       Impact factor: 7.853

6.  Simulations suggest pharmacological methods for rescuing long-term potentiation.

Authors:  Paul Smolen; Douglas A Baxter; John H Byrne
Journal:  J Theor Biol       Date:  2014-07-15       Impact factor: 2.691

Review 7.  Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function.

Authors:  Junji Egawa; Matthew L Pearn; Brian P Lemkuil; Piyush M Patel; Brian P Head
Journal:  J Physiol       Date:  2015-10-14       Impact factor: 5.182

Review 8.  Robotic devices as therapeutic and diagnostic tools for stroke recovery.

Authors:  Bruce T Volpe; Patricio T Huerta; Johanna L Zipse; Avrielle Rykman; Dylan Edwards; Laura Dipietro; Neville Hogan; Hermano I Krebs
Journal:  Arch Neurol       Date:  2009-09

Review 9.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

Review 10.  ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors:  David M G Halpin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.